HIGHLIGHTS
- who: Biprojit Bhowmick from the Department of Pharmacology, Seacom Pharmacy College, Jaladhulagori, Sankrail, Howrah, West Bengal, India, have published the paper: Tumor suppressor genes and their interactions and neo-adjuvant therapy in paclitaxel resistance in cancer, in the Journal: (JOURNAL)
- what: Paclitaxel`s introduction throughout the last two decades has extended therapy choices for various types of cancer patients.
- future: Ongoing and future trials will look at nab-efficacy paclitaxel`s in all subtypes of breast cancer including TNBC which has a high sensitivity to this therapeutic method. Future trials should include molecular . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.